Form: EFFECT

Notice of Effectiveness

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: June 20, 2025
Accession Number: 0001104659-25-060003
Submission Type: POS AM
CIK: 0001427570
Company Name: ReShape Lifesciences Inc.
File Number: 333-282459